Among US adults without diabetes, the use of GLP-1 RAs increased from 2018 to 2022, reaching annual prevalence of 0.4% in 2022.

A preclinical study by scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory ...

Claims that a Texas-based drug compounder violated state unfair-competition laws when it decided to manufacture and sell copycat versions of a rheumatoid arthritis drug are not preempted by federal ...

The company's rheumatoid arthritis drug Humira, the most lucrative therapy ever, lost U.S. patent exclusivity in early 2023. AbbVie returned to top-line growth last year, and investors can expect ...

were statistically significantly associated with decreased risk of Alzheimer disease and related dementias compared with other glucose-lowering drugs, and no difference was observed between both drugs ...

In particular, the finding that GLP-1 RA drugs may perform better than SGLT-2i drugs “suggests that the dementia protection effects are not due to glucose control mechanisms” and that ...

MINNEAPOLIS — A Mexican national orchestrated a multinational drug-smuggling operation in Minnesota that was affiliated with the notorious Sureños cartel, according to grand jury indictments ...

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India to import ...

The frequency of sex after 60 may be different than it is for people in their 20s, 30s, 40s, and even 50s, but that does not mean that older adults do not want or enjoy sex. That said, physical ...

Enhertu reduced the risk of disease progression or death by 38% vs. chemotherapy in HR+, HER2-low metastatic breast cancer patients. AstraZeneca owes Daiichi Sankyo a $125 million milestone ...